ATRA Stock Analysis: Buy, Sell, or Hold?
ATRA - Atara Biotherapeutics, Inc
$8.55
0.17 (2.03%)
▲
5d:
+10.89%
30d:
-26.61%
90d:
+74.49%
BUY
MODERATE Confidence
Analysis Updated: Aug 3, 2026 12:00 AM ET
Earnings: Aug 10, 2026
5d
Get Alerted When ATRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: ATRA shows positive signals but monitor for confirmation. Market pricing in 24.3% decline. Moderate conviction.
💡 BUY OPPORTUNITY: ATRA shows positive signals but monitor for confirmation. Market pricing in 24.3% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$27.58
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$17.13
50.1% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 15.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ATRA is currently trading at $8.55, which is considered fair relative to its 30-day fair value range of $7.91 to $10.46. From a valuation perspective, the stock is trading at a discount (Forward PE: 6.7) compared to its historical average (15.5). Remarkably, the market is currently pricing in an annual earnings decline of 24.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ATRA is in a strong uptrend. The price is approaching resistance at $8.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.67 (+59.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ATRA is in a strong uptrend. The price is approaching resistance at $8.68. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $13.67 (+59.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$7.91 -
$10.46
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 59.8% below Wall St target ($13.67)
Trading Range Analysis
30-Day Trading Range
$7.91 -
$10.46
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$7.39
Resistance Level
$8.68
Current Trend
Strong Uptrend
Technical data as of
Aug 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
6.73
Wall Street Target
$13.67
(+59.8%)
Revenue Growth (YoY)
-99.5%
Profit Margin
-40.9%
Valuation Discount vs History
-24.3% cheaper
PE vs Historical
6.7 vs 15.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-24.3%
(market-implied from PE analysis)
1-Year Target
$7.70
(-10%)
2-Year Target
$6.93
(-19%)
3-Year Target
$6.23
(-27%)
3-Yr Target (if PE normalizes)
(PE: 7→16)
$14.35
(+68%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 6.7 to 15.5
Stabilization Target:
$19.68
(+130.2%)
PE Expansion Potential:
+130.2%
Share & Embed Analysis
Last updated: August 04, 2026 8:25 AM ET
Data refreshes hourly during market hours. Next update: 9:25 AM
Data refreshes hourly during market hours. Next update: 9:25 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$282 | 57 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
19 analysts |
$34 | 55 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$33 | 57 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
19 analysts |
$105 | 56 HOLD |
